
ASTH
Astrana Health, Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
55.87
PEG
—
P/B
1.58
P/S
0.39
EV/EBITDA
14.81
DCF Value
$71.62
FCF Yield
8.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
9.7%
Operating Margin
2.5%
Net Margin
0.7%
ROE
2.9%
ROA
2.1%
ROIC
2.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $950.5M | $6.0M | $0.12 |
| FY 2025 | $3.18B | $22.5M | $0.46 |
| Q3 2025 | $956.0M | $373.0K | $0.01 |
| Q2 2025 | $654.8M | $9.4M | $0.19 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.77
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.